Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH
SBI Mutual Fund · Managed by Tanmaya Desai
17weak
Latest NAV
₹600.1975
as of 07 Aug 2026
AUM
—
Expense ratio
1.03%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
17/100weak
Rank #834 of 1007 · top 83%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
6.10%
3M
13.65%
6M
26.72%
1Y
22.63%
3Y CAGR
24.06%
5Y CAGR
18.36%
Since incep.
18.42%
Fund details
- Fund manager
- Tanmaya Desai
- Riskometer
- Very High Risk
- Type
- Open Ended
- Portfolio turnover
- 33%
- Volatility (3Y)
- 16.2%
- Rating (external)
- —
Investment objective
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap36.0%
Mid cap27.5%
Small cap36.5%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 30 Jun 2026.
Sun Pharmaceutical Industries Ltd.
equity
11.18%
Acutaas Chemicals Ltd.
equity
6.35%
Divi's Laboratories Ltd.
equity
5.92%
Apollo Hospitals Enterprise Ltd.
equity
5.21%
Max Healthcare Institute Ltd.
equity
5.08%
Aurobindo Pharma Ltd.
equity
4.17%
Aster DM Healthcare Ltd.
equity
3.77%
Laurus Labs Ltd.
equity
3.64%
Cipla Ltd.
equity
3.52%
Torrent Pharmaceuticals Ltd.
equity
3.33%
Biocon Ltd.
equity
3.14%
Gland Pharma Ltd.
equity
3.00%
Fortis Healthcare Ltd.
equity
2.87%
Mankind Pharma Ltd.
equity
2.85%
Anthem Biosciences Ltd.
equity
2.84%
Aether Industries Ltd.
equity
2.72%
Jupiter Life Line Hospitals Ltd.
equity
2.56%
Sai Life Sciences Ltd.
equity
2.47%
Sudeep Pharma Ltd.
equity
2.31%
Krishna Institute of Medical Sciences Ltd.
equity
2.17%
Polymedicure Ltd.
equity
2.16%
Ajanta Pharma Ltd.
equity
2.05%
Cohance Lifesciences Ltd.
equity
2.01%
Lupin Ltd.
equity
1.94%
Concord Biotech Ltd.
equity
1.84%
Global Health Ltd.
equity
1.47%
Abbott India Ltd.
equity
1.22%
Nephrocare Health Service Pvt. Ltd.
equity
1.08%
Dr. Lal Path labs Ltd.
equity
0.99%
Rainbow Children's Medicare Ltd.
equity
0.85%